Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma

NCT04710134 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Asthma; Eosinophilic

Interventions

BIOLOGICAL: Reslizumab

Sponsor

McMaster University

Collaborators

[object Object]